The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) (MagnaSafe)
The MagnaSafe Registry: Determining the Risks of MRI in the Presence of Pacemakers and Implantable Cardioverter Defibrillators
Sponsor: Abbott Medical Devices
Listed as NCT00907361, this observational or N/A phase trial focuses on Implantable Cardioverter Defibrillator Implanted and Need for MRI Imaging With Pacemaker or and remains completed. Sponsored by Abbott Medical Devices, it has been updated 8 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2019 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Apr 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Biotronik, Inc.
- Boston Scientific Corporation
- Scripps Clinic
- Scripps Health
For direct contact, visit the study record on ClinicalTrials.gov .